Metabolomic Technologies Inc Medical Equipment Deals and Alliances Profile...
SummaryMetabolomic Technologies Inc MTI is a diagnostic company that develops metabolomicbased diagnostic systems. The company's products comprise ColoDx PolypDx BreastDx ProstateDx CeliacDx ColitisDx...
View ArticleFOPO nets $18.8mm for RedHill
Gastrointestinal diseasefocused RedHill Biopharma Ltd. netted $18.8mm through the followon public offering of 2.86mm American Depositary Shares ADSs; each represents ten ordinary shares at $7 each. The...
View ArticleReference Infliximab Biosimilar Equivalent for Crohn's Disease
TUESDAY Dec. 11 2018 CTP13 which is a biosimilar of the reference product RP infliximab has equivalent effectiveness for infliximabnaive patients with Crohn's disease CD according to a study published...
View ArticleInfliximab Biosimilar CTP13 for Crohn Disease Appears Effective
A large equivalence study shows similarity in efficacy and safety with the original formulation.
View ArticleYour NEJM Group Today Laryngocele Image Biosimilar for Crohn's California IM...
Check out what we found for you around NEJM Group NEJM HospitalistPrimary Care Page Images in clinical medicine A 58yearold man presented...
View ArticleBiosimilar CTP13 Matches Infliximab for Crohn's Disease
Crohn's disease was effectively and safely treated either with infliximab or with the biosimilar CTP13 according to an observational cohort study of more than 5000 patients. Medscape Medical News
View ArticleComparison of reference Infliximab and a Biosimilar CTP13 in Crohn's Disease...
MedPage Today Analysis of realworld data show that CTP13 is equivalent to infliximab in infliximabnaive patients with CD
View ArticleMetabolomic Technologies Inc Medical Equipment Deals and Alliances Profile...
SummaryMetabolomic Technologies Inc MTI is a diagnostic company that develops metabolomicbased diagnostic systems. The company's products comprise ColoDx PolypDx BreastDx ProstateDx CeliacDx ColitisDx...
View ArticlePredictImmune Awarded Innovate UK Grant to Apply its BiomarkerBased...
Developer of the PredictSURE IBD prognostic test awarded £100K from Innovate UKs Precision medicine technologies shaping the future fund to support feasibility study. PredictImmune developer of...
View ArticleJanssen Recruits Microbiome Company to Fight Inflammatory Bowel Disease
The Israeli biotech BiomX has teamed up with Janssen to use its microbiome technology in the treatment of inflammatory bowel diseases such as Crohns disease. Janssen aims to use BiomXs technology to...
View ArticleInflammatory bowel disease tied to heart attack risk
Reuters Health People with inflammatory bowel diseases like Crohn's disease and ulcerative colitis may be up to 12 times more likely to have a heart attack a U.S. study suggests.
View ArticleKOL Perspectives JAK Inhibitor Safety in IBD Report Updated 01052018 Prices...
KOL Perspectives JAK Inhibitor Safety in IBDSummaryThis KOL Insight briefing focuses on the potential use of selective JAK inhibitors in IBD.The briefing includes analysis of KOL opinion on the...
View ArticleuBiome Receives Patent for MicrobiomeDerived Diagnostics and Therapeutics for...
The leader in microbial genomics was granted a patent for the method and system of microbiomederived diagnostics and therapeutics.SAN FRANCISCO PRWEB December 14 2018 uBiome the leader in microbial...
View ArticleGenerex Biotechnology Partner Regentys Corporation Receives European Patent...
Regentys Extracellular Matrix Hydrogel ECMH Advances Regenerative Medicine Approach for Inflammatory Bowel Diseases Generex Biotechnology Corporation OTCQBGNBT announced today that Regentys Corporation...
View ArticleCrohn's Colitis May Be Tied to Prostate Cancer
FRIDAY Dec. 14 2018 Men with inflammatory bowel disease have a significantly greater risk of prostate cancer a new study finds.About 1 million men in the United States have inflammatory bowel disease...
View ArticleExclusive Enteral Nutrition Unneeded in Crohn's
MedPage Today Pilot study suggests ordinary wholefoods diet produces same effects in GI tract
View ArticleChallenges Persist for Severe Crohn's
MedPage Today "Perfect may be the enemy of good enough" expert says
View ArticleCelltrion Healthcare Co Ltd 091990 Pharmaceuticals Healthcare Deals and...
SummaryCelltrion Healthcare Co Ltd Celltrion is engaged in distributing marketing and selling of biosimilar and biological medicines. Its products include Remsima and Truxima. Remsima is a biosimilar...
View ArticleKOL Perspectives Implementation of the treattotarget approach in IBD Report...
KOL Perspectives Implementation of the treattotarget approach in IBDSummaryThis KOL Insight briefing focuses on KOLs views of implementation of the treattotarget approach in IBD.The briefing includes...
View Article